title: Use of tiotropium Respimat versus HandiHaler and mortality in patients with COPD.
authors.affiliation: Erasmus Medical Center, Dept of Medical Informatics, Rotterdam, The Netherlands k.verhamme@erasmusmc.nl.
authors.forename: Katia M C
authors.initials: KM
authors.lastname: Verhamme
authors.affiliation: Erasmus Medical Center, Dept of Medical Informatics, Rotterdam, The Netherlands.
authors.forename: Miriam C J M
authors.initials: MC
authors.lastname: Sturkenboom
authors.affiliation: Ghent University Hospital, Dept of Respiratory Medicine, Ghent, Belgium Erasmus Medical Center, Dept of Epidemiology, Rotterdam, The Netherlands.
authors.forename: Guy G O
authors.initials: GG
authors.lastname: Brusselle
mesh_terms: D001993:Bronchodilator Agents / Q000008:administration & dosage*; D016503:Drug Delivery Systems / Q000009:adverse effects*; D058995:Dry Powder Inhalers / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D012602:Scopolamine Derivatives / Q000008:administration & dosage*
chemical_list: D001993:Bronchodilator Agents; D012602:Scopolamine Derivatives